Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biolife Solutions (BLFS)

Biolife Solutions (BLFS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,932,843
  • Shares Outstanding, K 40,700
  • Annual Sales, $ 48,090 K
  • Annual Income, $ 2,670 K
  • 60-Month Beta 1.42
  • Price/Sales 38.93
  • Price/Cash Flow 321.74
  • Price/Book 4.76
Trade BLFS with:

Options Overview

Details
  • Implied Volatility 56.22%
  • Historical Volatility 82.15%
  • IV Percentile 17%
  • IV Rank 24.54%
  • IV High 93.37% on 03/08/21
  • IV Low 44.14% on 09/10/21
  • Put/Call Vol Ratio 3.00
  • Today's Volume 12
  • Volume Avg (30-Day) 129
  • Put/Call OI Ratio 0.60
  • Today's Open Interest 8
  • Open Int (30-Day) 92

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.02
  • Number of Estimates 3
  • High Estimate 0.04
  • Low Estimate 0.00
  • Prior Year -0.02
  • Growth Rate Est. (year over year) +200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.50 +9.17%
on 08/19/21
60.67 -21.72%
on 09/01/21
+3.18 (+7.18%)
since 08/17/21
3-Month
40.65 +16.83%
on 06/18/21
60.67 -21.72%
on 09/01/21
+5.26 (+12.46%)
since 06/17/21
52-Week
24.56 +93.36%
on 09/22/20
60.67 -21.72%
on 09/01/21
+22.06 (+86.75%)
since 09/17/20

Most Recent Stories

More News
BioLife Solutions Appoints Joydeep Goswami, MBA, PhD to Board of Directors

/PRNewswire/ --  ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today...

BLFS : 47.49 (+3.26%)
BioLife Solutions Announces CFO Retirement

/PRNewswire/ -- , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma...

BLFS : 47.49 (+3.26%)
Biolife Solutions Reaches Analyst Target Price

In recent trading, shares of Biolife Solutions Inc have crossed above the average analyst 12-month target price of $58.43, changing hands for $60.50/share. When a stock reaches the target an analyst...

BLFS : 47.49 (+3.26%)
BioLife Solutions Files Form S-3 Registration Statement to Register Shares from Completed Acquisitions

/PRNewswire/ -- (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma...

BLFS : 47.49 (+3.26%)
BioLife Solutions Closes Acquisition of Sexton Biotechnologies

/PRNewswire/ --  (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma...

BLFS : 47.49 (+3.26%)
BioLife Solutions Joins S&P SmallCap 600 Index

/PRNewswire/ -- ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today...

BLFS : 47.49 (+3.26%)
Bio-Techne Set to Join S&P 500; Saia, Mimecast & Option Care Health to Join S&P MidCap 400; Others to Join S&P SmallCap 600

/PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 effective prior to the opening of trading on :

OPTN : 2.87 (+0.70%)
BLFS : 47.49 (+3.26%)
USCR : 73.99 (-0.01%)
ADI : 168.98 (-1.48%)
MIME : 66.05 (-2.02%)
MXIM : 103.14 (-1.18%)
OPCH : 25.75 (+0.78%)
SAIA : 244.81 (-0.94%)
SYKE : 54.00 (+0.04%)
TECH : 534.35 (+0.92%)
TRMK : 30.53 (+1.19%)
CNK : 17.26 (-3.84%)
VMC : 167.00 (-1.70%)
SPGI : 446.42 (-1.68%)
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?

Sector ETF report for XHE

XHE : 131.79 (+0.71%)
BLFS : 47.49 (+3.26%)
LNTH : 25.60 (-0.16%)
IHI : 65.14 (-1.48%)
TMDX : 30.14 (-4.92%)
MDEV : 27.70 (-0.07%)
BioLife Solutions, Inc. (BLFS) Q2 Earnings and Revenues Top Estimates

BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of 480.00% and 10.19%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?...

BLFS : 47.49 (+3.26%)
BioLife Solutions Announces Second Quarter 2021 Financial Results

/PRNewswire/ -- ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today...

BLFS : 47.49 (+3.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of...

See More

Key Turning Points

3rd Resistance Point 51.35
2nd Resistance Point 49.62
1st Resistance Point 48.55
Last Price 47.49
1st Support Level 45.75
2nd Support Level 44.02
3rd Support Level 42.95

See More

52-Week High 60.67
Last Price 47.49
Fibonacci 61.8% 46.88
Fibonacci 50% 42.61
Fibonacci 38.2% 38.35
52-Week Low 24.56

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar